Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| WAVE LIFE SCIENCES | 16 | 2 | +5,61 % | ||
| ANAPTYSBIO | 7 | 2 | 0,00 % | ||
| ROCKET PHARMACEUTICALS | 7 | - | -14,45 % | ||
| AUTOLUS THERAPEUTICS | 7 | - | -10,43 % | ||
| HUMACYTE | 6 | 4 | -11,39 % | ||
| ZENAS BIOPHARMA | 6 | - | -21,24 % | ||
| MEIRAGTX | 5 | - | 0,00 % | ||
| KYVERNA THERAPEUTICS | 5 | - | +2,50 % | ||
| ARS PHARMACEUTICALS | 4 | - | -4,55 % | ||
| VOR BIOPHARMA | 4 | - | +5,63 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16:06 | Kyverna Therapeutics files $300M mixed securities shelf | 1 | Seeking Alpha | ||
| 16:00 | Sanofi gains EU approval recommendation for Scarlisa subcutaneous version | 6 | Seeking Alpha | ||
| 15:54 | William Blair reiterates Outperform on ARS Pharma stock after FDA label update | 2 | Investing.com | ||
| 15:46 | Vericel-Aktie erreicht Jahrestief bei 29,21 USD | 1 | Investing.com Deutsch | ||
| 15:42 | Piper Sandler cuts MeiraGTx stock price target on valuation | 1 | Investing.com | ||
| 15:34 | WVE Posts Interim Data From Phase I Study on WVE-007, Stock Tanks | 1 | Zacks | ||
| 15:30 | Autolus Q4 2025 slides: strong launch overshadowed by wider loss | 3 | Investing.com | ||
| 15:29 | Rocket Pharmaceuticals Shares Fall 13% Despite FDA Approval For KRESLADI Gene Therapy | 6 | RTTNews | ||
| 15:18 | Aclaris Therapeutics, Inc.: Results Presented at 2026 American Academy of Dermatology (AAD) Annual Meeting Provide Additional Support for the Therapeutic Potential of ATI-2138 | 2 | GlobeNewswire (USA) | ||
| 15:18 | Humacyte shares see BTIG price target cut to $3 on lower sales outlook | 1 | Investing.com | ||
| 15:10 | Autolus Therapeutics verfehlt Prognosen für Q4 2025 - Aktie bricht ein | 3 | Investing.com Deutsch | ||
| 15:10 | BTIG senkt Kursziel für Humacyte auf 3 US-Dollar nach schwacher Umsatzprognose | 1 | Investing.com Deutsch | ||
| 15:06 | ADMA Biologics Slams Short Seller Claims, Highlights Strong Demand | 2 | Benzinga.com | ||
| 14:59 | AnaptysBio Authorizes $100 Mln Stock Repurchase Plan | - | RTTNews | ||
| 14:54 | Mizuho reiterates Axsome stock Outperform rating on Rx data | 1 | Investing.com | ||
| 14:54 | Mizuho downgrades Terns Pharmaceuticals stock rating on Merck deal | 4 | Investing.com | ||
| 14:42 | Merck Agrees to Acquire Terns for $6.7B | 5 | Contract Pharma | ||
| 14:34 | Castle Biosciences: Neue Daten belegen Nutzen des Melanom-Tests bei der Risikostratifizierung | 2 | Investing.com Deutsch | ||
| 14:30 | AnaptysBio spinoff First Tracks Bio raises $80M in placement | 1 | Investing.com | ||
| 14:30 | AnaptysBio authorizes $100M stock buyback, plans spin-off | 1 | Investing.com |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.